You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

binimetinib

Showing 1 - 25 of 88
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Melanoma Stage III, Melanoma Stage IV Trial in San Francisco (Binimetinib, Imatinib)

Recruiting
  • Melanoma Stage III
  • Melanoma Stage IV
  • San Francisco, California
    University of California, San Francisco
Dec 6, 2022

Melanoma, BRAF V600 Mutation, Unresectable Melanoma Trial in Rennes (Binimetinib Oral Tablet)

Completed
  • Melanoma
  • +3 more
  • Binimetinib Oral Tablet
  • Rennes, France
    Biotrial
Mar 31, 2023

ive is Encorafenib Plus Binimetinib in Real-world and Clinical

Not yet recruiting
  • Metastatic Melanoma
  • (no location specified)
Jul 12, 2023

Healthcare Resource Utilization and Costs in Metastatic Melanoma

Terminated
  • Metastatic Melanoma
    • East Hanover, New Jersey
      Novartis Investigational Site
    Apr 27, 2023

    Solid Tumor Trial in Toronto (Binimetinib, Encorafenib)

    Recruiting
    • Solid Tumor
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Sep 23, 2022

    Metastatic Uveal Melanoma Trial in Tampa (Binimetinib, Belinostat)

    Recruiting
    • Metastatic Uveal Melanoma
    • Tampa, Florida
      Moffitt Cancer Center
    Jun 21, 2022

    Colorectal Cancer, Colon Cancer, BRAF V600E Trial (Binimetinib)

    Not yet recruiting
    • Colorectal Cancer
    • +4 more
    • Binimetinib
    • (no location specified)
    Aug 18, 2022

    NSCLC, KRAS Mutation-Related Tumors Trial in Philadelphia (Binimetinib Pill, Hydroxychloroquine Pill)

    Recruiting
    • Non-Small Cell Lung Cancer
    • KRAS Mutation-Related Tumors
    • Binimetinib Pill
    • Hydroxychloroquine Pill
    • Philadelphia, Pennsylvania
      Abramson Cancer Center of the University of Pennsylvania
    Sep 30, 2022

    Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma, Pathologic Stage IV Cutaneous Melanoma AJCC v8 Trial in

    Recruiting
    • Clinical Stage IV Cutaneous Melanoma AJCC v8
    • +2 more
    • Binimetinib
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 9, 2022

    Melanoma Stage III, Melanoma Stage IV, BRAF V600 Mutation Trial in Tampa (Encorafenib Pill, Binimetinib Pill, Nivolumab)

    Recruiting
    • Melanoma Stage III
    • +2 more
    • Encorafenib Pill
    • +2 more
    • Tampa, Florida
      Moffitt Cancer Center
    May 27, 2022

    Melanoma Trial in Worldwide (encorafenib, binimetinib, pembrolizumab)

    Recruiting
    • Melanoma
    • Siena, Toscana, Italy
    • +11 more
    Jun 23, 2023

    Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Refractory Malignant Solid Tumor Trial in Boston, Galveston,

    Suspended
    • Advanced Malignant Solid Neoplasm
    • +4 more
    • BET Bromodomain Inhibitor ZEN-3694
    • Binimetinib
    • Boston, Massachusetts
    • +2 more
    Oct 5, 2022

    Malignant Solid Tumor, Ovarian Low Grade Serous Adenocarcinoma, Pancreatic Carcinoma Trial (Binimetinib, Biopsy, Biospecimen

    Not yet recruiting
    • Malignant Solid Neoplasm
    • +4 more
    • Binimetinib
    • +6 more
    • (no location specified)
    Nov 8, 2022

    BRAF NP_004324.2:p.V600M, BRAF V600E Mutation Present, Metastatic Thyroid Gland Carcinoma Trial in Portland (Binimetinib,

    Recruiting
    • BRAF NP_004324.2:p.V600M
    • +6 more
    • Binimetinib
    • +2 more
    • Portland, Oregon
      Providence Portland Medical Center
    Aug 17, 2022

    Anatomic Stage IV Breast Cancer AJCC v8, Metastatic HER2-Negative Breast Carcinoma, Metastatic Hormone Receptor-Positive Breast

    Not yet recruiting
    • Anatomic Stage IV Breast Cancer AJCC v8
    • +2 more
    • Binimetinib
    • +5 more
    • (no location specified)
    Nov 8, 2022

    RAS Mutation, NRAS Gene Mutation, Melanoma Trial in Phoenix, Newnan, Zion (OKI-179 + binimetinib)

    Recruiting
    • RAS Mutation
    • +2 more
    • OKI-179 + binimetinib
    • Phoenix, Arizona
    • +4 more
    Sep 22, 2022

    Colorectal Carcinoma, Lung Adenocarcinoma, Malignant Solid Tumor Trial in Buffalo (Binimetinib, Palbociclib, Therapeutic

    Recruiting
    • Colorectal Carcinoma
    • +3 more
    • Binimetinib
    • +2 more
    • Buffalo, New York
      Roswell Park Cancer Institute
    May 11, 2022

    Advanced or Metastatic Solid Tumors Irrespective of Gene Alterations, NSCLC, KRAS Gene Mutation Trial in Santa Monica,

    Recruiting
    • Advanced or Metastatic Solid Tumors Irrespective of Gene Alterations
    • +2 more
    • Futibatinib and Binimetinib
    • Santa Monica, California
    • +2 more
    Jun 2, 2022

    Metastatic Malignant Tumor in the Brain, Metastatic Melanoma, Stage III Cutaneous Melanoma AJCC v7 Trial in Houston (drug,

    Active, not recruiting
    • Metastatic Malignant Neoplasm in the Brain
    • +7 more
    • Binimetinib
    • +6 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jun 15, 2022

    Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma, Metastatic Microsatellite Stable Colorectal Carcinoma

    Terminated
    • Metastatic Colon Adenocarcinoma
    • +27 more
    • Binimetinib
    • +3 more
    • San Francisco, California
    • +1 more
    Jan 5, 2023

    Malignant Melanoma, BRAF V600 Mutation, Brain Metastases Trial in France (Stereotaxic radiosurgery (SRS), Binimetinib Oral

    Recruiting
    • Malignant Melanoma
    • +2 more
    • Stereotaxic radiosurgery (SRS)
    • +3 more
    • Bobigny, France
    • +20 more
    Oct 7, 2022

    Melanoma Stage III, In-Transit Metastasis of Cutaneous Melanoma Trial in Leiden (Encorafenib + Binimetinib)

    Recruiting
    • Melanoma Stage III
    • In-Transit Metastasis of Cutaneous Melanoma
    • Encorafenib + Binimetinib
    • Leiden, Zuid-Holland, Netherlands
      Leiden University Medical Center
    Mar 2, 2023

    Gastrointestinal Stromal Tumors Trial (Ripretinib, binimetinib)

    Withdrawn
    • Gastrointestinal Stromal Tumors
    • (no location specified)
    Dec 15, 2021

    Melanoma Trial in Pittsburgh (encorafenib, nivolumab, ipilimumab)

    Recruiting
    • Melanoma
    • Pittsburgh, Pennsylvania
      UPMC Hillman Cancer Center
    Mar 24, 2022

    Lung Cancer Trial in Boston (Binimetinib, Palbociclib)

    Recruiting
    • Lung Cancer
    • Boston, Massachusetts
    • +1 more
    Jan 18, 2022